AIRS at a glance
Airsculpt Technologies, Inc. (AIRS, SEC CIK 1870940) filed its latest 10-K annual report on March 31, 2026, a 10-Q quarterly report on August 10, 2026, an 8-K current report on August 12, 2026 and Form 4 insider filings as recently as May 20, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Airsculpt Technologies, Inc. (AIRS) reported revenue of $151.8 million (down 15.8% from FY2024) and a net loss of $11.7 million. Diluted EPS was -$0.19.
- As of June 30, 2026, 18 institutional investment managers tracked by SignalX reported holding Airsculpt Technologies, Inc. (AIRS) shares worth $16.6 million in 13F-HR filings.
- The most recent insider open-market purchase reported on Form 4 was by Chernett Jorey on April 17, 2026 of 40,000 shares at $2.54 per share.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $151.8M
- −15.8% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 18 funds
- $16.6M · −1 vs prior quarter
- Latest 8-K
- Aug 12, 2026
- Item 8.01
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Q2 revenue $42.9M, down 2.5% from $44.0M YoY
- Operating margin (0.1%) vs 1.8% YoY; net loss margin (2.6%) vs (1.3%)
- Same-center cases up 1.0%, while revenue per case fell 2.0% to $12,707
- Cash $18.8M; operating cash flow $4.0M versus $5.9M YoY
- ATM proceeds $5.0M in Q2; $12.7M debt principal payments in six months
Risk Factors
- No material changes to 2025 10-K risk factors disclosed
- Credit facility maturity extended to November 15, 2027 from May 11, 2027
- $2.5 million lender payment due upon amendment signing and another $2.5 million by September 30, 2026
- 50% of future equity issuance proceeds required for term-loan prepayment
- Investment banks required if obligations remain undischarged after October 31, 2026
AI summary of the AIRS 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 8.01: Other Events
- Corporate headquarters relocating from Miami Beach, Florida to Tampa, Florida
- Board-approved change effective for future SEC filings
Item 2.02: Results of Operations and Financial Condition
- Q2 and first-half 2026 results released for periods ended June 30, 2026
- Press release in Exhibit 99.1 contains financial results and management commentary
Item EX-99.1: Item EX-99.1
- Q2 revenue fell 3% to $42.9M, while cases declined 0.5% to 3,376 and revenue per case decreased 2.0% to $12,707
- Adjusted EBITDA dropped to $4.9M from $5.8M, compressing margin to 11.5% from 13.3%
Item 5.07: Submission of Matters to a Vote of Security Holders
- 93.49% shareholder participation, with 65,895,278 shares represented at the virtual annual meeting
- Adam Feinstein, Thomas Aaron, and Kenneth Higgins elected as Class II directors through the 2029 annual meeting
AI summaries of AIRS 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for AIRS
Don't miss the next AIRS filing
- Alerts as it files. A push when AIRS files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut AIRS, by share count.
- Ask anything. An AI agent that reads every AIRS filing and answers with sources.
AIRS alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Feinstein Adam T | J | May 20, 2026 | 5,169,820 | - |
| Aaron Thomas J | A | May 12, 2026 | 100,286 | - |
| Aaron Thomas J | A | May 12, 2026 | 100,286 | - |
| Higgins Kenneth | A | May 12, 2026 | 100,286 | - |
| Chu Caroline | A | May 12, 2026 | 100,286 | - |
| Chernett Jorey | Buy | Apr 17, 2026 | 40,000 | $2.54 |
| Chernett Jorey | E | Apr 17, 2026 | 2,004 | - |
| Chernett Jorey | E | Apr 17, 2026 | 2,000 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $180.3M | $151.8M |
| Operating Income | - | -$1.8M | -$11.6M |
| Net Income | -$4.5M | -$8.3M | -$11.7M |
| Op. Margin | - | -1.0% | -7.6% |
| Net Margin | - | -4.6% | -7.7% |
| Balance Sheet | |||
| Total Assets | $204.0M | $210.0M | $187.3M |
| Equity | - | $79.3M | $87.7M |
| ROE | - | -10.4% | -13.3% |
| Per Share | |||
| EPS | $-0.08 | $-0.14 | $-0.19 |
| Cash Flow | |||
| Operating CF | $24.0M | $11.3M | $3.1M |
| CapEx | - | $14.0M | $2.4M |
Source: XBRL data in Airsculpt Technologies, Inc. (AIRS)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate AIRS share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 18 | $16.6M |
| Q1 2026 | 19 | $7.5M |
| Q4 2025 | 22 | $9.5M |
| Q3 2025 | 20 | $24.5M |
| Q2 2025 | 21 | $15.2M |
| Q1 2025 | 13 | $2.9M |
| Q4 2024 | 8 | $5.2M |
| Q3 2024 | 4 | $1.9M |
- BlackRock+474.8K (+59%)
- AQR Capital Management+161.4K (+52%)
- Vanguard Capital Management LLC+53.8K (+23%)
- Goldman Sachs Group+49.2K (+26%)
- Morgan Stanley+32.6K (+89%)
- Vanguard Portfolio Management LLC−74.8K (-54%)
- Citigroup−25.1K (-25%)
- BNY Mellon−10.4K (-29%)
- Two Sigma Investments−4.3K (-7%)
- FMR LLC (Fidelity)−1.9K (-35%)
- Millennium Management+373.3K
- Dimensional Fund Advisors+32.3K
- Citadel Advisors LLC−62.5K
- Invesco Ltd−24.3K
- Bank of America Corp−11.9K
Source: 13F-HR filings on SEC EDGAR (aggregated from 125 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
AIRS filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Aug 12, 2026 | - | Analysis | - |
| 10-Q | Aug 10, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Aug 10, 2026 | - | Analysis | - |
| SC 13G | Jun 1, 2026 | - | - | |
| 4 | May 20, 2026 | - | - | |
| 4 | May 14, 2026 | - | - | |
| 4 | May 14, 2026 | - | - | |
| 8-K | May 14, 2026 | - | Analysis | |
| 4 | May 14, 2026 | - | - | |
| 8-K | May 8, 2026 | - | Analysis | |
| 10-Q | May 8, 2026 | Mar 31, 2026 | Analysis | |
| 4 | Apr 20, 2026 | - | - | - |
| 4 | Apr 15, 2026 | - | - | - |
| 4 | Apr 10, 2026 | - | - | - |
| 4 | Apr 10, 2026 | - | - | - |
| 4 | Apr 10, 2026 | - | - | - |
| 4 | Apr 8, 2026 | - | - | - |
| 8-K | Apr 6, 2026 | - | Analysis | - |
| 4 | Apr 6, 2026 | - | - | - |
| 8-K | Apr 2, 2026 | - | Analysis | - |
| 10-K | Mar 31, 2026 | Dec 31, 2025 | - | |
| 4 | Mar 25, 2026 | - | - | - |
| 4 | Mar 23, 2026 | - | - | - |
| 4 | Mar 20, 2026 | - | - | - |
| 4 | Mar 20, 2026 | - | - | - |
Related Health Care companies
- HIMS · Hims & Hers Health, Inc.Services-Offices & Clinics of Doctors of Medicine
- LFMD · LifeMD, Inc.Services-Offices & Clinics of Doctors of Medicine
- TOI · Oncology Institute, Inc.Services-Offices & Clinics of Doctors of Medicine
- SBC · SBC Medical Group Holdings IncServices-Offices & Clinics of Doctors of Medicine
- TDOC · Teladoc Health, Inc.Services-Offices & Clinics of Doctors of Medicine
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
AIRS SEC filings: frequently asked questions
Which institutions hold AIRS stock?
As of June 30, 2026, the largest Airsculpt Technologies, Inc. (AIRS) holders among the 13F filers tracked by SignalX were BlackRock ($5.8 million), AQR Capital Management ($2.1 million), Millennium Management ($1.7 million), Citizens Financial Group ($1.3 million), Vanguard Capital Management LLC ($1.3 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was AIRS's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Airsculpt Technologies, Inc. (AIRS) reported revenue of $151.8 million (down 15.8% from FY2024) and a net loss of $11.7 million. Diluted EPS was -$0.19. The figures come from the XBRL data in the 10-K.
What did AIRS report in its latest 8-K?
Airsculpt Technologies, Inc. (AIRS) filed an 8-K on August 12, 2026 reporting Item 8.01 (Other Events). Corporate headquarters relocating from Miami Beach, Florida to Tampa, Florida.
What are the latest AIRS SEC filings?
Airsculpt Technologies, Inc. (AIRS) filed its latest 10-K annual report on March 31, 2026, a 10-Q quarterly report on August 10, 2026, an 8-K current report on August 12, 2026 and a Form 4 insider filing on May 20, 2026.
What is AIRS's SEC CIK number?
Airsculpt Technologies, Inc. (AIRS)'s SEC Central Index Key (CIK) is 1870940. EDGAR lists every AIRS filing under that number.
Ask anything about AIRS
The research agent reads AIRS's filings, financials, insider trades and 13F holders, then answers with sources.